Focus Stocks

Below Support: GlaxoSmithKline

New York, June 4th (TradersHuddle.com) - Shares of GlaxoSmithKline plc (NYSE:GSK) closed the trading session at $43.45 below calculated support at $43.55. The stock broke down technically, raising concerns as the move might trigger additional selling.

GlaxoSmithKline plc (NYSE:GSK) is a research-based pharmaceutical group that develops, manufactures and markets vaccines, prescription and over-the-counter medicines, as well as health-related consumer products. Its over the counter medicines and health related consumer products are marketed under brand names like Panadol, Nicorette, Breathe Right, Tums, Aquafresh, and Sensodyne among others.

GlaxoSmithKline's stock was trading in a well defined range with support at $43.55 and resistance at $47.48; given that this range was broken traders will be closely monitoring the stock's price action for clues of direction.

From a technical perspective, it can be expected that previous support becomes resistance, as the new range gets defined. However, $43.55 will remain in focus as GlaxoSmithKline's price action places the stock near the broken support. Traders will be waiting to see if it can bounce back and return to its previous range.

Traders wanting to establish a short position in GlaxoSmithKline can do so if the stock breaks the intraday low, or if the stock bounces back and selling materializes again at previous support of $43.55. However, if traders want to build a long position, the best entry point to do so is when the price action takes the stock back to calculated support.